238 related articles for article (PubMed ID: 35979160)
1. Drug-induced autoimmune hepatitis: A minireview.
Tan CK; Ho D; Wang LM; Kumar R
World J Gastroenterol; 2022 Jun; 28(24):2654-2666. PubMed ID: 35979160
[TBL] [Abstract][Full Text] [Related]
2. Drug-induced autoimmune hepatitis: clinical characteristics and prognosis.
Björnsson E; Talwalkar J; Treeprasertsuk S; Kamath PS; Takahashi N; Sanderson S; Neuhauser M; Lindor K
Hepatology; 2010 Jun; 51(6):2040-8. PubMed ID: 20512992
[TBL] [Abstract][Full Text] [Related]
3. A case of synthetic oestrogen-induced autoimmune hepatitis with microvesicular steatosis.
Morii K; Nishisaka M; Nakamura S; Oda T; Aoyama Y; Yamamoto T; Kishida H; Okushin H; Uesaka K
J Clin Pharm Ther; 2014 Oct; 39(5):573-6. PubMed ID: 24989642
[TBL] [Abstract][Full Text] [Related]
4. Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): An expert opinion meeting report.
Andrade RJ; Aithal GP; de Boer YS; Liberal R; Gerbes A; Regev A; Terziroli Beretta-Piccoli B; Schramm C; Kleiner DE; De Martin E; Kullak-Ublick GA; Stirnimann G; Devarbhavi H; Vierling JM; Manns MP; Sebode M; Londoño MC; Avigan M; Robles-Diaz M; García-Cortes M; Atallah E; Heneghan M; Chalasani N; Trivedi PJ; Hayashi PH; Taubert R; Fontana RJ; Weber S; Oo YH; Zen Y; Licata A; Lucena MI; Mieli-Vergani G; Vergani D; Björnsson ES;
J Hepatol; 2023 Sep; 79(3):853-866. PubMed ID: 37164270
[TBL] [Abstract][Full Text] [Related]
5. Relapse and Need for Extended Immunosuppression: Novel Features of Drug-Induced Autoimmune Hepatitis.
Weber S; Gerbes AL
Digestion; 2023; 104(3):243-248. PubMed ID: 36603570
[TBL] [Abstract][Full Text] [Related]
6. Infliximab-induced autoimmune hepatitis.
Jenkins A; Austin A; Hughes K; Sadowski B; Torres D
BMJ Case Rep; 2021 May; 14(5):. PubMed ID: 34031069
[TBL] [Abstract][Full Text] [Related]
7. [Clinical features of drug-induced autoimmune hepatitis and drug-induced liver injury: a comparative analysis].
Zhao SX; Zhang YG; Tan PF; Wang RQ; Nan YM
Zhonghua Gan Zang Bing Za Zhi; 2016 Apr; 24(4):302-6. PubMed ID: 27470631
[TBL] [Abstract][Full Text] [Related]
8. Natural history and outcomes in drug-induced autoimmune hepatitis.
Yeong TT; Lim KH; Goubet S; Parnell N; Verma S
Hepatol Res; 2016 Mar; 46(3):E79-88. PubMed ID: 25943838
[TBL] [Abstract][Full Text] [Related]
9. CD4
Qu LM; Wang SH; Yang K; Brigstock DR; Sun L; Gao RP
Hepatobiliary Pancreat Dis Int; 2018 Apr; 17(2):133-139. PubMed ID: 29551296
[TBL] [Abstract][Full Text] [Related]
10. Differential characteristics in drug-induced autoimmune hepatitis.
Martínez-Casas OY; Díaz-Ramírez GS; Marín-Zuluaga JI; Muñoz-Maya O; Santos O; Donado-Gómez JH; Restrepo-Gutiérrez JC
JGH Open; 2018 Jun; 2(3):97-104. PubMed ID: 30483571
[TBL] [Abstract][Full Text] [Related]
11. Drug-induced autoimmune-like hepatitis.
Czaja AJ
Dig Dis Sci; 2011 Apr; 56(4):958-76. PubMed ID: 21327704
[TBL] [Abstract][Full Text] [Related]
12. Ornidazole-induced autoimmune hepatitis.
Ersöz G; Vardar R; Akarca US; Tekın F; Yilmaz F; Günşar F; Karasu Z
Turk J Gastroenterol; 2011 Oct; 22(5):494-9. PubMed ID: 22234756
[TBL] [Abstract][Full Text] [Related]
13. Drug-induced liver injury with autoimmune features.
deLemos AS; Foureau DM; Jacobs C; Ahrens W; Russo MW; Bonkovsky HL
Semin Liver Dis; 2014 May; 34(2):194-204. PubMed ID: 24879983
[TBL] [Abstract][Full Text] [Related]
14. Features of Autoimmune Hepatitis in Patients With Drug-induced Liver Injury.
de Boer YS; Kosinski AS; Urban TJ; Zhao Z; Long N; Chalasani N; Kleiner DE; Hoofnagle JH;
Clin Gastroenterol Hepatol; 2017 Jan; 15(1):103-112.e2. PubMed ID: 27311619
[TBL] [Abstract][Full Text] [Related]
15. Setting up criteria for drug-induced autoimmune-like hepatitis through a systematic analysis of published reports.
Björnsson ES; Medina-Caliz I; Andrade RJ; Lucena MI
Hepatol Commun; 2022 Aug; 6(8):1895-1909. PubMed ID: 35596597
[TBL] [Abstract][Full Text] [Related]
16. 'De novo' and 'recurrent' autoimmune hepatitis after liver transplantation: A comprehensive review.
Kerkar N; Yanni G
J Autoimmun; 2016 Jan; 66():17-24. PubMed ID: 26377632
[TBL] [Abstract][Full Text] [Related]
17. Acute liver injury following methylprednisolone pulse therapy: 13 cases from a prospectively collected cohort.
Allgeier J; Weber S; Todorova R; Neumann J; Gerbes A
Eur J Gastroenterol Hepatol; 2022 Apr; 34(4):457-461. PubMed ID: 35230981
[TBL] [Abstract][Full Text] [Related]
18. Autoimmune-like drug-induced liver injury: a review and update for the clinician.
Stine JG; Northup PG
Expert Opin Drug Metab Toxicol; 2016 Nov; 12(11):1291-1301. PubMed ID: 27402321
[TBL] [Abstract][Full Text] [Related]
19. Minocycline-Induced Autoimmune Hepatitis: A Rare But Important Cause of Drug-Induced Autoimmune Hepatitis.
Harmon EG; McConnie R; Kesavan A
Pediatr Gastroenterol Hepatol Nutr; 2018 Oct; 21(4):347-350. PubMed ID: 30345250
[TBL] [Abstract][Full Text] [Related]
20. Early ALT response to corticosteroid treatment distinguishes idiosyncratic drug-induced liver injury from autoimmune hepatitis.
Weber S; Benesic A; Rotter I; Gerbes AL
Liver Int; 2019 Oct; 39(10):1906-1917. PubMed ID: 31319011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]